Abstract
Get full access to this article
View all access options for this article.
References
1.Bayer and Asklepios BioPharmaceutical. Bayer acquires Asklepios BioPharmaceutical to broaden innovation base in cell and gene therapy. 2020 . https://media.bayer.com/baynews/baynews.nsf/id/Bayer-acquires-Asklepios-BioPharmaceutical-to-broaden-innovation-base-in-cell-and-gene-therapy (last accessed
November 13 , 2020
).
2.
Genetic Engineering & Biotechnology News. Expanding gene therapy presenceBayer to acquire AskBio for up to $4B. 2020. https://www.genengnews.com/news/expanding-gene-therapy-presence-bayer-to-acquire-askbio-for-up-to-4b/ (last accessed
November 14 , 2020
).
3.Novartis.
Novartis acquires Vedere
Bio
, adding novel optogenetic gene therapy technology for treating blindness. 2020. https://www.novartis.com/news/media-releases/novartis-acquires-vedere-bio-adding-novel-optogenetic-gene-therapy-technology-treating-blindness (last accessed
November 13 , 2020
).
4.
Philippidis
A. A
new vision for gene therapy. Genetic engineering & biotechnology news. 2020. https://www.genengnews.com/gen-edge/a-new-vision-for-gene-therapy/ (last accessed
November 13 , 2020
).
5.Homology Medicines. Homology Medicines announces $60 million equity investment from Pfizer Inc. 2020 . https://www.homologymedicines.com/news-story/homology-medicines-announces-60-million-equity-investment-from-pfizer-inc (last accessed
November 13 , 2020
).
6.
BioMarin
Pharmaceutical
.
BioMarin Pharmaceutical to European Medicines
Agency
, November 4, 2020.
Withdrawal of
Roctavian
, valoctocogene roxaparvovec, 2 x 1013 vector genomes/ml, solution for infusion,
for marketing authorisation application
EM
EA/H/C/0004749. 2020. https://www.ema.europa.eu/en/documents/withdrawal-letter/withdrawal-letter-roctavian_en.pdf (last accessed
November 15 , 2020
).
7.
The Motley
Fool
.
Biomarin Pharmaceutical
Inc.
, (BMRN) Q3 2020 earnings call transcript. 2020. https://www.fool.com/earnings/call-transcripts/2020/11/07/biomarin-pharmaceutical-inc-bmrn-q3-2020-earnings/ (last accessed
November 15 , 2020
).
8.UCB. UCB strengthens its gene therapy activities with additional pipeline programs, capabilities, and platforms. 2020 . https://www.prnewswire.com/news-releases/ucb-strengthens-its-gene-therapy-activities-with-additional-pipeline-programs-capabilities-and-platforms-301171455.html (last accessed
November 14 , 2020
).
9.
Lacerta
Therapeutics
.
Lacerta Therapeutics signs gene therapy research partnership with
UCB
. 2020. https://lacertatx.com/lacerta-therapeutics-signs-gene-therapy-research-partnership-with-ucb/ (last accessed
November 14 , 2020
).
10.Decibel Therapeutics. Decibel Therapeutics announces $82M Series D financing to advance gene therapies to restore hearing and balance. 2020 . https://www.decibeltx.com/decibel-therapeutics-announces-82m-series-d-financing-to-advance-gene-therapies-to-restore-hearing-and-balance/ (last accessed
November 14 , 2020
).